Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.

Study Overview
=================
Brief Summary
-----------------
Local anesthetics (LA) are increasingly used for postoperative pain management. Speicifically, several studies have found benefit of LA injected intra-abdominally following abdominal hysterectomy. However, it remains unclear whether the pain relief seen is due to local anesthetic mechanisms within the abdominal cavity or through systemic absorption. The aim of this study is to assess whether lidocaine administered intravenously has similar analgesic efficacy as the same dose administered intra-abdominally in patients undergoing abdominal hysterectomy. All patients would have rescue analgesia using the patient controlled analgesia (PCA) pump with morphine in order to achieve adequate pain management during 24 h.

Detailed Description
-----------------
Abdominal hysterectomy with or without salipingo-oophorectomy is associated with moderate-severe postoperative pain. Poor pain control in the postoperative period can lead to increased postoperative morbidities and poor quality of life. Furthermore, an emerging clinical literature suggests that acute pain may rapidly evolve into chronic pain if poorly treated. A meta-analysis of the literature found that > 30% patients had chronic pain one year after abdominal hysterectomy (5). Therefore, efficient postoperative pain management is imperative for the patient and is one of the new pain management standards recommended recently. Local anesthetics (LA) have been infiltrated subcutaneously, infused intra-abdominally, as well as injected into the peritoneal cavity as a single dose at the end of the operation following abdominal hysterectomy with variable effects. When injected as a single dose, analgesia is limited to approximately 2-4 hours due to the short duration of action of local anesthetics. In one recent study, the authors used a catheter inserted intra-abdominally and local anesthetic or placebo infusion into the abdominal cavity for 24 h postoperatively and found a reduction in postoperative analgesic requirements by 40% during 4-24 h. In another study, the investigators found that LA injected intermittently intra-abdominally resulted in better pain relief compared to intra-abdominal infusions.

Official Title
-----------------
A Comparison Between Continuous Infusion vs. Patient Controlled Intraabdominal Injection of Local Anesthetics for Treatment of Postoperative Pain After Abdominal Hysterectomy. A Randomized, Double-blind Study.

Conditions
-----------------
Uterine Myoma, Persistent Post-menpausal Bleeding, Uterine Cancer

Intervention / Treatment
-----------------
* Drug: Normal saline
* Drug: Intravenous Lidocaine
* Drug: Intra-abdominal Lidocaine


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: ASA 1-2 30 - 75 yrs Informed consent 50 - 100 kg Exclusion Criteria: Allergy to LA Chronic pain Major liver/kidney insufficiency AV Block 1-2 Participation in another clinical trial

Ages Eligible for Study
-----------------
Minimum Age: 30 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Intravenous Lidocaine<br>Intravenous lidocaine would be administered as an infusion for pain management both intra- and post-operatively. | Drug: Intravenous Lidocaine<br>* Standardized infusion of lidocaine during 24 h. 100 mg bolus and 50 mg/h during 24 h would be administered.<br>* Other names: Xylocaine 5 mg/ml;|
| Active Comparator: Intra-abdominal Lidocaine<br>Lidocaine would be administered intermittently, once each hour intra-abdominally for postoperative pain management. | Drug: Intra-abdominal Lidocaine<br>* Lidocaine 5 mg/ml; 100 mg would be administered intraoperatively intra-abdominally and subsequently 50 mg/h as intermittent injection intra-abdominally during 24 h<br>* Other names: Xylocaine 5 mg/ml;|
| Placebo Comparator: Normal saline<br>Normal saline would be administered intra-abdominally and intravenously in the same patient. Rescue analgesia in the form of morphine (PCA) would be used for pain management. | Drug: Normal saline<br>* Normal saline would be administered intravenously and intra-abdominally.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Morphine consumption | Total rescue morphine consumption during 0 - 24 h would be the primary endpoint | 0 - 24 h postoperatively | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Postoperative pain | Postoperative pain measured on the numeric rating scale (0 - 10) would be measured at 4 h | 4 h postoperatively | 
| Plasma concentration of lidocaine | The plasma concentration of LA lidocaine would be analysed at 24 h in order to assess whether the LA absorption from the abdomen is similar to that administered intravenously. | 24 h | 
| Length of Hospital stay | The time to discharge home would be assessed using standardized criteria for home discharge. | 1-5 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Surgery: Abdominal hysterectomy, Anesthetics: Local, Postoperative: Pain, Drugs: Morphine